Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and above.
Expert review of vaccines（2022）
摘要
This trial was registered with ClinicalTrials.gov (NCT05313646).
更多查看译文
关键词
Ad5-nCoV,Batch consistency,COVID-19 vaccine,RBD-specific IgG,clinical trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要